![Benzamide,N-[3-[[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl]oxy]phenyl]-4-[2-(4-morpholinyl)ethoxy]-](https://static.cymitquimica.com/cas-image/340142-benzamide-n-3-2-4-amino-125-oxadiazol-3-yl-1-ethyl-1h-imidazo-45-c-pyridin-6-yl-oxy-phenyl-4-2-4-morpholinyl-ethoxy.png)
CAS: 850664-21-0 - Benzamide,N-[3-[[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl]oxy]phenyl]-4-[2-(4-morpholinyl)ethoxy]-
Formula:C29H30N8O5
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | GSK269962A REF: AN-AG00G3OHCAS: 850664-21-0 | 98% | To inquire | Tue 21 May 24 |
 | GSK269962A REF: TM-T3518CAS: 850664-21-0 | 99.59% | 42.00 €~639.00 € | Tue 28 May 24 |
 | GSK 269962 REF: TR-G797840CAS: 850664-21-0 | - - - | 90.00 €~178.00 € | Fri 28 Jun 24 |
 | GSK 269962 REF: 3D-BG164808CAS: 850664-21-0 | Min. 95% | To inquire | Mon 01 Jul 24 |
Ref: AN-AG00G3OH
| 5mg | 159.00 € | |
| 10mg | 247.00 € | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 21 May 2024
GSK269962A
CAS:850664-21-0
GSK269962A (GSK269962A HCl) is a selective ROCK(Rho-associated protein kinase) inhibitor with IC50 values of 1.6 …
Formula:
C29H30N8O5
Purity:
99.59%
Color and Shape:
Solid
Molecular weight:
570.6
Ref: TM-T3518
| 1mg | 42.00 € | |
| 2mg | 56.00 € | |
| 5mg | 89.00 € | |
| 10mg | 147.00 € | |
| 25mg | 300.00 € | |
| 50mg | 445.00 € | |
| 100mg | 639.00 € | |
| 1ml*10 (DMSO) | 104.00 € |
Estimated delivery in United States, on Tuesday 28 May 2024
GSK 269962
Controlled ProductCAS:850664-21-0
Formula:
C29H30N8O5
Color and Shape:
Off-White Solid
Molecular weight:
570.6
Ref: TR-G797840
| 1mg | 90.00 € | |
| 5mg | 143.00 € | |
| 10mg | 178.00 € |
Estimated delivery in United States, on Friday 28 Jun 2024
GSK 269962
CAS:850664-21-0
Inhibitor of Rho-associated protein kinase
Formula:
C29H30N8O5
Purity:
Min. 95%
Molecular weight:
570.6 g/mol
Ref: 3D-BG164808
| 10mg | To inquire | |
| 50mg | To inquire |
Estimated delivery in United States, on Monday 1 Jul 2024
